Literature DB >> 22885189

Tuberculosis chemotherapy : present situation, possible solutions, and progress towards a TB-free world.

Noton K Dutta, Petros C Karakousis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22885189     DOI： 10.4103/0255-0857.99481

Source DB:  PubMed          Journal:  Indian J Med Microbiol        ISSN： 0255-0857            Impact factor:   0.985


× No keyword cloud information.
  6 in total

1.  Reduced emergence of isoniazid resistance with concurrent use of thioridazine against acute murine tuberculosis.

Authors:  Noton K Dutta; Michael L Pinn; Petros C Karakousis
Journal:  Antimicrob Agents Chemother       Date:  2014-05-05       Impact factor: 5.191

2.  Potent rifamycin-sparing regimen cures guinea pig tuberculosis as rapidly as the standard regimen.

Authors:  Noton K Dutta; Abdullah Alsultan; Thomas J Gniadek; Deborah A Belchis; Michael L Pinn; Khisimuzi E Mdluli; Eric L Nuermberger; Charles A Peloquin; Petros C Karakousis
Journal:  Antimicrob Agents Chemother       Date:  2013-06-03       Impact factor: 5.191

3.  Thioridazine lacks bactericidal activity in an animal model of extracellular tuberculosis.

Authors:  Noton K Dutta; Michael L Pinn; Ming Zhao; Michelle A Rudek; Petros C Karakousis
Journal:  J Antimicrob Chemother       Date:  2013-03-05       Impact factor: 5.790

4.  Adjunctive Host-Directed Therapy With Statins Improves Tuberculosis-Related Outcomes in Mice.

Authors:  Noton K Dutta; Natalie Bruiners; Matthew D Zimmerman; Shumin Tan; Véronique Dartois; Maria L Gennaro; Petros C Karakousis
Journal:  J Infect Dis       Date:  2020-03-16       Impact factor: 5.226

5.  Comparative efficacy and acceptability of five anti-tubercular drugs in treatment of multidrug resistant tuberculosis: a network meta-analysis.

Authors:  Huaidong Wang; Xiaotian Zhang; Yuanxiang Bai; Zipeng Duan; Yan Lin; Guoqing Wang; Fan Li
Journal:  J Clin Bioinforma       Date:  2015-04-28

Review 6.  Safety and availability of clofazimine in the treatment of multidrug and extensively drug-resistant tuberculosis: analysis of published guidance and meta-analysis of cohort studies.

Authors:  Thomas J Hwang; Svetlana Dotsenko; Azizkhon Jafarov; Karin Weyer; Dennis Falzon; Kaspars Lunte; Paul Nunn; Ernesto Jaramillo; Salmaan Keshavjee; Douglas F Wares
Journal:  BMJ Open       Date:  2014-01-02       Impact factor: 2.692
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.